| KHM-3S | IC50 |
|---|---|
| Erlotinib | 0.5 μM |
| Erlotinib + HGF | >10 μM |
| Erlotinib + HGF + Crizotinib | 0.3 μM |
• HGF induces resistance to Erlotinib.
• Crizotinib blocks HGF-induced resistance to Erlotinib, restoring sensitivity.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.